What Cannovum does

Cannovum AG is a Berlin-headquartered, publicly traded pharmaceutical company (Aktiengesellschaft) founded in 2018 that imports and distributes cannabis-based medicines in the German market. The company is registered in the Frankfurt/Main commercial register (HRB 119297) and operates from Stresemannstraße 23 in Berlin. It was constituted from inception as a stock-exchange-traded public limited company (börsengehandelte Aktiengesellschaft), with Alexander Landgraf-Meltzer serving as the sole executive board member (Vorstand) and concurrently as Data Protection Officer (Datenschutzbeauftragter).

The company employs between 11 and 50 people per firmographic data. The source material is highly limited with respect to product portfolio, technology stack, pricing, distribution channels, customer segments, and go-to-market motion — these are explicitly listed as "Not disclosed in available sources." The company's public website (cannovum.com) consists almost entirely of corporate identity, contact, and German-language legal/privacy notices; there is no named product line, platform architecture, or technology component described in the provided data. A separate investor relations site (ir.cannovum.com) is referenced, consistent with its listed-company status.

From a capital-structure standpoint, Cannovum is described as a public stock corporation with no disclosed parent company, no documented subsidiaries, and no private equity or venture capital ownership signals identified in the source material. Financial table values included in the input are not internally consistent with a 11–50 employee specialty pharmaceutical distributor and are treated as unreliable data artifacts rather than reported figures; the company's actual revenue, profitability, and cash position are not credibly disclosed in the available material.

Name

Cannovum

Legal name

CANNOVUM CANNABIS AG

Website

https://cannovum.com

Company type

Public

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Cannovum AG is a Berlin-based, publicly traded pharmaceutical company (Aktiengesellschaft) that imports and distributes cannabis-based medicines in Germany, operating since 2018 as a stock-exchange-listed entity.

Ownership category

akta.pro rank

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales

Core offering

Cannovum (legally CANNOVUM CANNABIS AG) is a Berlin-based pharmaceutical company that imports and distributes cannabis-based medicines in Germany. Founded in 2018 as a stock-exchange traded Aktiengesellschaft, the company operates as a pharmaceutical importer and distributor focused on medical cannabis products for the German healthcare market.

Product overview

Based on the available source data, CANNOVUM AG is a publicly listed stock corporation (Aktiengesellschaft) incorporated in 2018 and headquartered in Berlin, Germany. The source material does not contain specific details about the company's product or service offerings, product portfolio, or technology platform. The scraped content is limited to corporate identity information, investor relations pages, contact details, and legal/privacy notices. No named products, modules, or services are described in the provided data.

Differentiator

Problem solved

Functional benefit

Products and services

• Cannabis-based medicines Imported and distributed cannabis-based pharmaceutical products supplied to pharmacies, hospitals, and healthcare professionals in Germany.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves2 records

Expansion highlights1 record

Broad incumbents

• Canopy Growth Corporation: Canadian-listed global cannabis operator active across European medical markets including Germany. Comparable medical cannabis category, but operating at materially larger scale and breadth than Cannovum.
• Aurora Cannabis Inc. Large Canadian cannabis producer with European operations targeting Germany's medical market. Comparable medical cannabis category and German-channel ambitions, but at substantially larger and broader scale.
• Stada Arzneimittel AG: Major German generic pharmaceutical company that has moved into medical cannabis distribution through partnerships. Comparable end-market (German pharmacies) but at vastly broader pharma scale and product breadth.
• Tilray Brands Inc. Global cannabis company with strong German medical cannabis distribution presence through Tilray Deutschland. Comparable distribution-to-German-pharmacy model, but at much larger international scale.

Direct peers

• Demecan Holding GmbH: German medical cannabis cultivator, manufacturer and wholesaler. Comparable vertically integrated business serving the same German medical cannabis patient base as Cannovum.
• Cansativa GmbH: German medical cannabis importer and distributor operating from Frankfurt. Directly comparable to Cannovum on product category (medical cannabis), market (Germany), and business model (wholesale distribution to pharmacies).
• Sanity Group GmbH: Berlin-based cannabis healthcare company covering cultivation, distribution and pharma. Comparable German cannabis start-up building end-to-end medical cannabis supply chain.
• Nimbus Health GmbH: German medical cannabis importer and distributor serving pharmacies. Closely overlaps Cannovum on wholesale distribution of cannabis-based medicines in Germany under BfArM licensing.

Regional players

• Schwabe Pharma AG & Co. KG: Major German phytopharmaceutical company producing plant-based medicines including cannabis-based preparations. Comparable botanical pharmaceutical manufacturing serving German pharmacy channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat1 record

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/cannovum
• Facebookfacebook.com/cannovum

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cannovum